Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wraith

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Current Opinion in Immunology|September 21, 2010
Antigen-specific immunotherapy of autoimmune and allergic diseasesCatherine A Sabatos-Peyton, Johan Verhagen, David C Wraith
Frontiers in Immunology|August 15, 2020
Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver DiseasesNaomi Richardson, Sky T H Ng, David C Wraith
Current Opinion in Immunology|October 30, 2004
Regulatory CD4+ T cells and the control of autoimmune diseaseDavid C Wraith, Kirsty S Nicolson, Nathaniel T Whitley
Journal of Neuroimmunology|July 29, 2006
IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAEEmma J O'Neill, Michael J Day, David C Wraith
Plos One|September 20, 2014
Ctla-4 modulates the differentiation of inducible Foxp3+ Treg cells but IL-10 mediates their function in experimental autoimmune encephalomyelitisJohan Verhagen, Leona Gabryšová, Ella R Shepard, et al.
The Lancet. Rheumatology|January 27, 2024
Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapyHendrik J Nel, Vivianne Malmström, David C Wraith, et al.
Journal of Neuroimmunology|October 7, 2004
Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoireDavid McCue, Kelli R Ryan, David C Wraith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivoAnette Sundstedt, Emma J O'Neill, Kirsty S Nicolson, et al.
Endocrinology|August 13, 2018
Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic MiceLiselotte Jansson, Kathleen Vrolix, Andrea Jahraus, et al.
Journal of Molecular and Cellular Cardiology|April 23, 2017
A humanized HLA-DR4 mouse model for autoimmune myocarditisM Emrah Şelli, Anita C Thomas, David C Wraith, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Current Opinion in Immunology|September 21, 2010
Antigen-specific immunotherapy of autoimmune and allergic diseasesCatherine A Sabatos-Peyton, Johan Verhagen, David C Wraith
Frontiers in Immunology|August 15, 2020
Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver DiseasesNaomi Richardson, Sky T H Ng, David C Wraith
Current Opinion in Immunology|October 30, 2004
Regulatory CD4+ T cells and the control of autoimmune diseaseDavid C Wraith, Kirsty S Nicolson, Nathaniel T Whitley
Journal of Neuroimmunology|July 29, 2006
IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAEEmma J O'Neill, Michael J Day, David C Wraith
Plos One|September 20, 2014
Ctla-4 modulates the differentiation of inducible Foxp3+ Treg cells but IL-10 mediates their function in experimental autoimmune encephalomyelitisJohan Verhagen, Leona Gabryšová, Ella R Shepard, et al.
The Lancet. Rheumatology|January 27, 2024
Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapyHendrik J Nel, Vivianne Malmström, David C Wraith, et al.
Journal of Neuroimmunology|October 7, 2004
Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoireDavid McCue, Kelli R Ryan, David C Wraith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivoAnette Sundstedt, Emma J O'Neill, Kirsty S Nicolson, et al.
Endocrinology|August 13, 2018
Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic MiceLiselotte Jansson, Kathleen Vrolix, Andrea Jahraus, et al.
Journal of Molecular and Cellular Cardiology|April 23, 2017
A humanized HLA-DR4 mouse model for autoimmune myocarditisM Emrah Şelli, Anita C Thomas, David C Wraith, et al.
Pageof 10